Freya Ventures
Overview
Freya Ventures is a platform advising and investing in startups in the health & family tech space. The firm invests primarily in Seed and Series A opportunities, supporting management with new market entry, business development, and fundraising . Chantal Noble Haldorsen is an early stage investor focused primarily on healthcare and family tech, with a portfolio of over 40 investments across Europe and North America. She is originally from Oslo, Norway, and is currently based in London .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Paterna Biosciences | Oct 2024 | Seed | Co-investor |
| Vivan Therapeutics | - | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Freya Ventures based?
Freya Ventures is headquartered in London, England, United Kingdom.
When was Freya Ventures founded?
Freya Ventures was founded in 2023.
How many portfolio companies does Freya Ventures have?
Freya Ventures has 2 portfolio companies in Caplight's dataset.
What are some companies in Freya Ventures's portfolio?
Portfolio companies visible on Caplight include Paterna Biosciences, Vivan Therapeutics.
What was Freya Ventures's most recent investment shown here?
Freya Ventures's most recent investment in this portfolio sample was in Paterna Biosciences in 2024.
What sectors does Freya Ventures focus on?
Freya Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Freya Ventures focus on?
Freya Ventures typically invests at the Early stage.
What is Freya Ventures's AUM?
Freya Ventures's assets under management are estimated between $0.0 and $50.0M.